EFFECTS OF SELEGILINE DOSING ON MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE

被引：21

作者：

HUBBLE, JP ^{[1
]}

KOLLER, WC ^{[1
]}

WATERS, C ^{[1
]}

机构：

[1] UNIV SO CALIF,DEPT NEUROL,LOS ANGELES,CA 90089

来源：

CLINICAL NEUROPHARMACOLOGY | 1993年 / 16卷 / 01期

关键词：

SELEGILINE; DEPRENYL; PARKINSON DISEASE; MOTOR FLUCTUATION;

D O I：

10.1097/00002826-199302000-00010

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

To examine selegiline's dosing effects, we studied 16 Parkinson disease patients with motor fluctuations in a double-blind, crossover trial of selegiline at 0, 5, and 10 mg daily. Patients' motor diaries, disability scores, and walking speed were marginally improved, with no advantage of 10 mg over 5 mg found. We conclude that in patients with motor fluctuations, selegiline provides modest symptomatic effects, with daily dosing of 5 mg being indistinguishable from 10 mg.

引用

页码：83 / 87

页数：5

共 50 条

[31] PROTON MR SPECTROSCOPY OF THE BRAIN IN 14 PATIENTS WITH PARKINSONS-DISEASE
BOWEN, BC
BLOCK, RE
SANCHEZRAMOS, J
PATTANY, PM
LAMPMAN, DA
MURDOCH, JB
QUENCER, RM
AMERICAN JOURNAL OF NEURORADIOLOGY, 1995, 16 (01) : 61 - 68
[32] ASSESSMENT OF DOPAMINERGIC RESPONSE IN PARKINSONS-DISEASE USING THE APOMORPHINE TEST
MIRANDA, M
SAEZ, D
REVISTA MEDICA DE CHILE, 1995, 123 (03) : 326 - 329
[33] COMPARISON OF 2 FORMS OF INTENSIVE SPEECH TREATMENT FOR PARKINSONS-DISEASE
RAMIG, LO
COUNTRYMAN, S
THOMPSON, LL
HORII, Y
JOURNAL OF SPEECH AND HEARING RESEARCH, 1995, 38 (06): : 1232 - 1251
[34] SOME NEW ASPECTS OF THE EFFECT OF (-)DEPRENYL IN PARKINSONS-DISEASE - A RETROSPECTIVE STUDY
MALLY, J
JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1992, 4 (02) : 155 - 164
[35] Effects of selegiline and rasagiline on disease progression in Parkinson's disease
Schulz, Joerg B.
BASAL GANGLIA, 2012, 2 (04) : S41 - S45
[36] EFFECTS OF AGRICULTURAL WORK AND OTHER PROXY-DERIVED CASE-CONTROL DATA ON PARKINSONS-DISEASE RISK ESTIMATES
SEMCHUK, KM
LOVE, EJ
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (08) : 747 - 754
[37] Parkinson’s disease: Motor fluctuations
Stewart A. Factor
Current Treatment Options in Neurology, 1999, 1 (1) : 21 - 32
[38] Effects of Selegiline in a retroviral rat model for neurodegenerative disease
Czub, M
Czub, S
Gosztonyi, G
Koutsilieri, E
Sopper, S
Müller, JG
Gerlach, M
Riederer, P
ter Meulen, V
JOURNAL OF NEUROVIROLOGY, 1999, 5 (05) : 458 - 464
[39] Emergence of non-motor fluctuations with reference to motor fluctuations in Parkinson's disease
Kim, Aryun
Kim, Han-Joon
Shin, Chae Won
Kim, Ahro
Kim, Yoon
Jang, Mihee
Jung, Yu Jin
Lee, Woong-Woo
Park, Hyeyoung
Jeon, Beomseok
PARKINSONISM & RELATED DISORDERS, 2018, 54 : 79 - 83
[40] Effects of monoamine oxidase Type B inhibitors on motor and non-motor symptoms in Parkinson's disease: A systematic comparison of rasagiline and selegiline
Loehle, Matthias
Storch, Alexander
BASAL GANGLIA, 2012, 2 (04) : S33 - S40

← 1 2 3 4 5 →